These findings indicate that the phosphorylation of tau at Thr217 might be related to a subtle and unique aspect of pathology that is different from the other isoforms.What drives this rise in plasma p-tau217 in AD and its underlying cellular pathological mechanism remains to be investigated. The gene discussed is MAPT; the disease is Alzheimer disease.